The global precision biotics market is on track to nearly double in size over the next five years, rising from $4.91 billion in 2026 to $9.26 billion by 2031 at a compound annual growth rate of 13.5%, according to a new forecast from research firm MarketsandMarkets. The projection underscores accelerating commercial interest in microbiome-targeted ingredients across functional foods, dietary supplements, and medical nutrition.
The Numbers
At a 13.5% CAGR, precision biotics is expanding roughly three times faster than the broader global food and beverage market, reflecting both scientific momentum and shifting consumer health priorities. The MarketsandMarkets analysis identifies next-generation probiotics (NGPs) — strains such as Akkermansia muciniphila and Faecalibacterium prausnitzii that were largely unviable in commercial formats until recently — as the fastest-growing type segment within the category. NGPs command premium price points and are increasingly appearing in clinically positioned supplement and functional food formulations.
Regional Dynamics
Asia Pacific is projected to be the fastest-growing regional market through 2031, buoyed by rising disposable incomes, government-backed nutrition initiatives, and a consumer base that has historically demonstrated strong receptivity to gut-health and fermented-food categories. Established markets in North America and Western Europe are expected to retain the largest absolute revenue shares, supported by robust retail infrastructure for functional foods and a dense network of contract manufacturers with fermentation expertise. For foodservice and ingredient suppliers operating across supply chains, the regional divergence signals different commercialization timelines and regulatory pathways.
What It Means for Operators
The precision biotics opportunity extends well beyond the supplement aisle. Food and beverage manufacturers are embedding probiotic and prebiotic ingredients into categories ranging from ambient snacks and beverages to refrigerated dairy alternatives and clinical medical nutrition products. The convergence of personalized nutrition — where formulations are matched to individual microbiome profiles — with mainstream retail is compressing what was once a niche, practitioner-only segment into a broadly accessible consumer market. Brands that have invested in clinically validated strains and transparent efficacy claims are best positioned to capture the premium tier as regulatory scrutiny of health claims intensifies in key markets.
For ingredient buyers and procurement teams, the growth trajectory implies tightening supply for validated probiotic strains and increased competition for co-manufacturing capacity. Operators tracking functional food and beverage ingredient trends should note that precision biotics is one of several science-backed categories — alongside adaptogens and postbiotics — reshaping the better-for-you segment. Coverage of adjacent market moves, including probiotic and gut-health product launches, reflects how quickly retail shelves are evolving in response to this demand curve.
The MarketsandMarkets report also flags cosmetics as an emerging application vertical, where topical microbiome products are attracting investment from both legacy beauty conglomerates and food-derived ingredient suppliers, further broadening the addressable market beyond core food and beverage channels.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.
